| Literature DB >> 27734959 |
Hanneke Ac van Helvoort1,2, Laura M Willems1,2, Pn Richard Dekhuijzen1, Hieronymus Wh van Hees1,2, Yvonne F Heijdra1.
Abstract
In patients with chronic obstructive pulmonary disease (COPD), exercise capacity is reduced, resulting over time in physical inactivity and worsened health status. It is unknown whether ventilatory constraints occur during activities of daily life (ADL) in early stages of COPD. The aim of this study was to assess respiratory mechanics during ADL and to study its consequences on dyspnoea, physical activity and health status in early-stage COPD compared with healthy controls. In this cross-sectional study, 39 early-stage COPD patients (mean FEV1 88±s.d. 12% predicted) and 20 controls performed 3 ADL: climbing stairs, vacuum cleaning and displacing groceries in a cupboard. Respiratory mechanics were measured during ADL. Physical activity was measured with accelerometry. Health status was assessed by the Nijmegen Clinical Screening Instrument. Compared with controls, COPD patients had greater ventilatory inefficiency and higher ventilatory requirements during ADL (P<0.05). Dyspnoea scores were increased in COPD compared with controls (P<0.001). During ADL, >50% of the patients developed dynamic hyperinflation in contrast to 10-35% of the controls. Higher dyspnoea was scored by patients with dynamic hyperinflation. Physical activity was low but comparable between both groups. From the patients, 55-84% experienced mild-to-severe problems in health status compared with 5-25% of the controls. Significant ventilatory constraints already occur in early-stage COPD patients during common ADL and result in increased dyspnoea. Physical activity level is not yet reduced, but many patients already experience limitations in health status. These findings reinforce the importance of early diagnosis of COPD and assessment of more than just spirometry.Entities:
Mesh:
Year: 2016 PMID: 27734959 PMCID: PMC5062564 DOI: 10.1038/npjpcrm.2016.54
Source DB: PubMed Journal: NPJ Prim Care Respir Med ISSN: 2055-1010 Impact factor: 2.871
Figure 1Lung volumes at rest and during exercise in healthy subjects and in patients with chronic obstructive pulmonary disease (COPD). In normal lungs, end-expiratory lung volume (EELV) remains relatively constant during exercise, as tidal volume can increase and inspiratory capacity (IC) is maintained. Patients with COPD breathe with a greater EELV and less IC. During exercise, as ventilation increases, the increased EELV (dynamic hyperinflation) pushes tidal volume closer to total lung capacity (TLC) where expansion is limited by high pressures. IC decreases and breathing becomes so restricted that patients have to stop activity. IRV, inspiratory reserve volume; RV, residual volume. From ref. 30 with permission.
Subject characteristics, lung function and pulmonary medication
| Age, years | 62±8 | 64±8 |
| Gender, m/f | 10/10 | 25/14 |
| BMI, kg/m2 | 25.9±4.9 | 27.4±5.2 |
| Pack-years, years | 6±9 | 25±18*** |
| Smoking status (% never/ex/current) | 55/35/10 | 0/85/15*** |
| MRC, 0/1/2/3 | 12/8/0/0 | 3/18/16/2*** |
| FEV1, l | 3.25±0.85 | 2.58±0.57** |
| FEV1, %pred | 112±15 | 88±12*** |
| FEV1/VC, % | 75±4 | 58±7*** |
| TLC, %pred | 109±11 | 116±13* |
| RV/TLC, % | 37±8 | 41±6* |
| SABA | 0% | 23% |
| SAMA | 0% | 3% |
| LAMA | 0% | 46% |
| LABA | 0% | 5% |
| ICS | 0% | 8% |
| Combined ICS/LABA | 0% | 31% |
| No inhalation medication | 100% | 28% |
Abbreviations: BMI, body mass index; f, female; FEV1, forced expiratory volume in 1 s; ICS, inhaled corticosteroid; LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antagonist; m, male; pred, predicted; RV, residual volume; SABA, short-acting β2-agonist; SAMA, short-acting muscarinic antagonist; TLC, total lung capacity; VC, vital capacity.
post-bronchodilator values for patients with COPD.
*P<0.05, **P<0.01, ***P<0.001 compared with controls.
Physiological responses to ADL
| VO2, l/min | 1.3±0.3 | 1.4±0.3 | 0.9±0.2 | 0.9±0.2 | 1.3±0.3 | 1.3±0.2 |
| VO2, %peak | 71±15 | 67±16 | 47±13 | 40±12 | 69±15 | 62±16 |
| VE, l/min | 37±7* | 31±8 | 27±6* | 23±6 | 36±8* | 29±6 |
| VE, %MVV | 39±11*** | 26±9 | 28±7*** | 20±7 | 37±10*** | 25±8 |
| Bf, per min | 24±6 | 21±4 | 24±5 | 23±4 | 24±6* | 21±6 |
| Vt, l | 1.65±0.40 | 1.55±0.28 | 1.17±0.32 | 1.06±0.21 | 1.61±0.56 | 1.64±0.49 |
| VE/VCO2 | 35±6** | 30±4 | 36±6** | 32±4 | 30±4 | 35±5** |
| IRV, l | 1.54±0.59 | 1.62±0.60 | 2.00±0.67 | 2.07±0.65 | 1.56±0.54 | 1.37±0.54 |
| ΔIC, l | −0.06±0.31** | 0.18±0.20 | −0.06±0.33** | 0.25±0.23 | −0.04±0.29 | 0.09±0.05 |
| ΔIC, %ICrest | −1.2±10.3** | 6.5±7.0 | −1.4±10.4** | 8.6±6.9 | −0.5±8.7 | 3.6±7.0 |
| BORG, dyspnoea | 2.6±1.5*** | 0.8±1.4 | 1.5±1.4*** | 0.5±0.7 | 2.3±1.5*** | 0.6±0.8 |
| Time, s | 46±9 | 43±6 | 300±0 | 300±0 | 81±13** | 70±14 |
Abbreviations: Bf, breathing frequency; IC, inspiratory capacity; IRV, inspiratory reserve volume; MVV, maximal voluntary ventilation; VE, ventilation; VO2, oxygen consumption; Vt, tidal volume.
*P<0.05 compared with controls; **P<0.01 compared with controls; ***P<0.001 compared with controls.
Figure 2Metabolic and ventilatory responses to vacuum cleaning. (a) Oxygen uptake (VO2), (b) minute ventilation (VE), (c) respiratory frequency (fR), (d) tidal volume (Vt), (e) inspiratory time (Ti) and expiratory time (Te) and (f) VE/carbon dioxide production (VCO2). Data are presented as mean±s.e.m. *P<0.05 at standardised time points.
Figure 3Dynamic hyperinflation (DH), expressed as change in IC, after different ADL. (a) Stair climbing, (b) vacuum cleaning and (c) displacing groceries in a cupboard. Percentages indicate proportion of subjects demonstrating a decrease in IC (hyperinflators).
Figure 4Mean physical activity of healthy controls compared with COPD. No significant differences were seen.
Figure 5Frequencies of patients and healthy controls experiencing normal functioning (white), mild (grey) or severe (black) problems in each sub-domain of the NCSI. *P<0.05 between groups.